Skip to main content
. 2017 Dec 6;83(3):677–686. doi: 10.1038/pr.2017.270

Table 3. Medical history of presenting complaints of subjects in the randomized arms at study baseline.

Medical history of presenting complaints as examined by clinician, N (%) Test (N=35) Control (N=36) Total (N=71)
Overall symptoms      
 A change in behavior such as irritability or crying 12 (34.3%) 19 (52.8%) 31 (43.7%)
       
Gastrointestinal symptoms      
 Frequent regurgitation or vomiting related to cow’s milk protein 23 (65.7%) 29 (80.6%) 52 (72.3%)
 Persistent distress or colic (>3 h/day ≥3 days/week over a 3-week period) 24 (68.6%) 25 (69.4%) 49 (69.0%)
 Soft stool constipation (with/without perianal rash due to infection) 12 (34.3%) 17 (47.2%) 29 (40.8%)
 Faltering growth after the dietary inclusion of cow’s milk protein 13 (37.1%) 11 (30.6%) 24 (33.8%)
 Extended periods of diarrhea with a negative stool examination 8 (22.9%) 9 (25.0%) 17 (23.9%)
 Blood in stool 10 (28.6%) 5 (13.9%) 15 (21.1%)
 Endoscopically confirmed eosinophilic enteropathy 0 0 0
       
Skin symptoms      
 Eczema 16 (45.7%) 21 (58.3%) 37 (52.1%)
 Urticaria 3 (8.6%) 4 (11.1%) 7 (9.9%)
       
Respiratory symptoms      
 Sneezing/nasal congestion 9 (25.7%) 12 (33.3%) 21 (29.6%)
 Wheezing 5 (14.3%) 5 (13.9%) 10 (14.1%)
 Conjunctivitis 1 (2.9%) 3 (8.3%) 4 (5.6%)
 Dyspnea 1 (2.9%) 1 (2.8%) 2 (2.8%)
 Stridor 1 (2.9%) 1 (2.8%) 2 (2.8%)
 Dysphonia 0 0 0
 Aphonia 0 0 0
       
Other symptoms      
Hypotension for age 0 0 0
       
Predominant complaint/stratification factor      
 Skin symptoms 4 (11.4%) 3 (8.3%) 7 (9.9%)
 Gastrointestinal symptoms 31 (88.6%) 33 (91.7%) 64 (90.1%)